Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes https://www.biorxiv.org/content/10.1101/2022.11.10.515949
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes https://www.biorxiv.org/content/10.1101/2022.11.10.515949